We are joined by biopharma expert Ivan Kairatov to discuss a groundbreaking discovery that redefines our understanding of IDH-mutant glioma, the most common malignant brain tumor in young adults. This conversation explores how this cancer begins not as a visible mass, but as a stealthy infiltration
A comprehensive analysis of recent oncological research has illuminated a remarkably promising therapeutic strategy for hepatocellular carcinoma (HCC), a notoriously aggressive and increasingly prevalent form of liver cancer. This investigation centers on the synergistic application of two natural
Pancreatic cancer has long maintained a daunting reputation as one of the most aggressive and difficult-to-treat malignancies, a challenge largely defined by its resistance to standardized therapies and the limitations of conventional research models. For patients and clinicians alike, the path of
New research from Princeton University’s Ludwig Institute for Cancer Research has untangled the complex and often harmful relationship between a vitamin A derivative and the body's ability to fight cancer, resolving a long-standing paradox about vitamin A's role in oncology and introducing a
For countless individuals who have undergone mastectomies, the journey toward physical and emotional recovery is often complicated by the limitations of existing reconstructive surgeries. A groundbreaking prototype of an injectable paste, developed by researchers from human skin cells and detailed
The formidable challenge in modern oncology is not just eliminating cancerous cells, but dismantling the sophisticated biological fortresses that solid tumors construct to shield themselves from the body's own immune system. While immunotherapy has revolutionized cancer treatment, its success
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27